Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteriaAlan J. Thompson, Jeffrey A. Cohen, Timothy Coetzee et al.|The Lancet Neurology|2017Cited by 8k
Ofatumumab versus Teriflunomide in Multiple SclerosisStephen L. Hauser, Ludwig Kappos, Amit Bar‐Or et al.|New England Journal of Medicine|2020Cited by 706
Multiple sclerosis progression: time for a new mechanism-driven frameworkTanja Kuhlmann, Emmaunelle Waubant, Marcello Moccia et al.|The Lancet Neurology|2022Cited by 624
Diagnosis of multiple sclerosis: 2024 revisions of the McDonald criteriaXavier Montalbán, Heinz Wiendl, Christine Lebrun‐Frénay et al.|The Lancet Neurology|2025Cited by 314
The Role of Astrocytes in Multiple Sclerosis ProgressionJorge Correale, Mauricio Farez|Frontiers in Neurology|2015Cited by 255